Sex and racial/ethnic differences in B-ALL genomics

B-ALL 基因组学中的性别和种族/民族差异

基本信息

  • 批准号:
    10555358
  • 负责人:
  • 金额:
    $ 15.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-01 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Project Summary Children with substantial African ancestry have long been known to have half or less the rate of B- cell acute lymphoblastic leukemia (B-ALL) than do children with other continental ancestries. Moreover, AA children have lower incidence despite having greater exposure to many putatively causal environmental risk factors for B-ALL than do white children. However, even within AA children, we still observe a 30% excess incidence of ALL among males compared to females at all ages and a remarkable 300% increased incidence at 12 years of age. The male excess may depend on sex-varying associations with the disease for germline genetics on the autosomes and the X chromosome, sex differences in immune function, and/or hormonal differences. Common genetic variants established by genomewide association studies (GWAS) incompletely explain the deficit of B-ALL in AA children, suggesting undiscovered contributing genetic factors may be detected by admixture mapping. Few studies examine GWAS by sex. The parent R01 of this Administrative Supplement, titled “Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study” (R01 CA239701), includes existing DNA samples and data for 930 B-ALL patients with AA ancestry and will accrue ~600 samples over the remaining project years. We are conducting admixture mapping in the assembled group of patients to detect new genetic loci and new variants at established loci associated with occurrence of B-ALL. In addition, we are examining admixture in association with clinical characteristics at diagnosis and survival. Candidate genes/variants will be functionally evaluated through both in silico and in vitro techniques. For the Administrative Supplement, we will conduct sex-stratified GWAS in AA children with B-ALL from the parent R01 and we will expand our analyses to include the X chromosome, which is generally excluded from GWAS. As part of this Award, we will generate a new source of genomic data from healthy AA children using umbilical cord hematopoietic stem cells, which we will use to map sex-differential expression quantitative trait loci for each sex thereby decreasing our search space for disease- relevant loci and increase our power to identify biologically relevant loci in AA males and females with B-ALL. Findings will be placed in context to those observed in AA children that we are currently generating as part of our other funded research. The proposed research will potentially answer a long-standing mystery by revealing critical genes or loci that may explain increased incidence of B-ALL in AA males. Identifying sex-varying associations between germline SNVs and childhood ALL will allow us to identify biologic mechanisms contributing to the observed sex differences in AA B-ALL incidence.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael E Scheurer其他文献

Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma
横纹肌肉瘤儿童的种系基因检测和生存结果
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Bailey A Martin;He Li;Michael E Scheurer;Dana L Casey;Shannon Dugan;Deborah A Marquez;D. Muzny;Richard A. Gibbs;D. Barkauskas;David Hall;Douglas R Stewart;J. Schiffman;Matthew T McEvoy;Javed Khan;D. Malkin;C. Linardic;B. Crompton;J. Shern;S. Skapek;R. Venkatramani;Douglas S. Hawkins;A. Sabo;Sharon E. Plon;Philip J. Lupo
  • 通讯作者:
    Philip J. Lupo

Michael E Scheurer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael E Scheurer', 18)}}的其他基金

Biospecimen & Biomarker Development Core
生物样本
  • 批准号:
    10657446
  • 财政年份:
    2022
  • 资助金额:
    $ 15.5万
  • 项目类别:
Biospecimen & Biomarker Development Core
生物样本
  • 批准号:
    10410754
  • 财政年份:
    2022
  • 资助金额:
    $ 15.5万
  • 项目类别:
Ethnic disparities in methotrexate neurotoxicity among children and adolescents with ALL
患有 ALL 的儿童和青少年中甲氨蝶呤神经毒性的种族差异
  • 批准号:
    10289496
  • 财政年份:
    2021
  • 资助金额:
    $ 15.5万
  • 项目类别:
Admixture analysis of acute lymphoblastic leukemia in African American children: the ADMIRAL Study
非裔美国儿童急性淋巴细胞白血病的混合分析:ADMIRAL 研究
  • 批准号:
    10307680
  • 财政年份:
    2021
  • 资助金额:
    $ 15.5万
  • 项目类别:
Ethnic disparities in methotrexate neurotoxicity among children and adolescents with ALL
患有 ALL 的儿童和青少年中甲氨蝶呤神经毒性的种族差异
  • 批准号:
    10683990
  • 财政年份:
    2021
  • 资助金额:
    $ 15.5万
  • 项目类别:
Ethnic disparities in methotrexate neurotoxicity among children and adolescents with ALL
患有 ALL 的儿童和青少年中甲氨蝶呤神经毒性的种族差异
  • 批准号:
    10472703
  • 财政年份:
    2021
  • 资助金额:
    $ 15.5万
  • 项目类别:
Investigator Development Core
研究者开发核心
  • 批准号:
    10376062
  • 财政年份:
    2020
  • 资助金额:
    $ 15.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10223897
  • 财政年份:
    2020
  • 资助金额:
    $ 15.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10690830
  • 财政年份:
    2020
  • 资助金额:
    $ 15.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10427341
  • 财政年份:
    2020
  • 资助金额:
    $ 15.5万
  • 项目类别:

相似海外基金

Understanding of the onset and recurrence pattern of intractable acute lymphocytic leukemia based on clone analysis
基于克隆分析了解难治性急性淋巴细胞白血病的发病和复发模式
  • 批准号:
    20K08723
  • 财政年份:
    2020
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
BCR-ABL 多重耐药突变体的新型抑制剂,用于治疗慢性粒细胞白血病 (CML) 和 Ph 阳性急性淋巴细胞白血病 (ALL)。
  • 批准号:
    9047400
  • 财政年份:
    2015
  • 资助金额:
    $ 15.5万
  • 项目类别:
The Role of Genetic Variants in Sensitivity to Methotrexate in Acute Lymphocytic Leukemia Survivors
遗传变异在急性淋巴细胞白血病幸存者对甲氨蝶呤敏感性中的作用
  • 批准号:
    319114
  • 财政年份:
    2014
  • 资助金额:
    $ 15.5万
  • 项目类别:
    Fellowship Programs
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的骨髓微环境
  • 批准号:
    8595788
  • 财政年份:
    2013
  • 资助金额:
    $ 15.5万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8023518
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8404025
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8220724
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
  • 批准号:
    8599754
  • 财政年份:
    2011
  • 资助金额:
    $ 15.5万
  • 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
  • 批准号:
    8356701
  • 财政年份:
    2010
  • 资助金额:
    $ 15.5万
  • 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
  • 批准号:
    8166720
  • 财政年份:
    2009
  • 资助金额:
    $ 15.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了